Raiffeisen Bank International’s Legend Biotech LEGN Stock Holding History

Raiffeisen Bank International’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Sell	80,000 -60,000	-43%	-$1.62M	0.03%	280
2026 Q1	$2.42M	Buy	140,000 +40,000	+40%	+$763K	0.03%	254
2025 Q4	$2.15M	Buy	100,000 +25,000	+33%	+$716K	0.03%	247
2025 Q3	$2.46M	Sell	75,000 -5,000	-6%	-$185K	0.03%	219
2025 Q2	$2.67M	Buy	+80,000	New	+$2.59M	0.04%	202

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Raiffeisen Bank International's LEGN Position: Q2 2026 in Review

Raiffeisen Bank International reduced its Legend Biotech (LEGN) stake by 43% in Q2 2026, selling an estimated $1.62M and leaving 80,000 shares worth $2.35M. The position accounts for 0.03% of the portfolio, ranked #280.

Raiffeisen Bank International first reported a position in LEGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.67M in Q2 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Raiffeisen Bank International held 80,000 shares of Legend Biotech worth $2.35M as of Q2 2026.
Raiffeisen Bank International sold 60,000 Legend Biotech shares in Q2 2026, an estimated $1.62M.
Legend Biotech made up 0.03% of Raiffeisen Bank International's portfolio in Q2 2026, its #280 holding.
Raiffeisen Bank International first reported a position in Legend Biotech in Q2 2025 and has held it in 5 quarters since.
Raiffeisen Bank International's Legend Biotech position peaked at $2.67M in Q2 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.